Julie Clauss is a biotech executive, entrepreneur, and investor dedicated to accelerating innovation so patients receive life-changing therapies faster. She is the CEO and Cofounder of Patient Partner Capital, where she partners with scientific founders to build patient-centered biotech companies grounded in operational excellence and strategic clarity.

With deep experience across R&D operations, portfolio strategy, and executive leadership, including executive roles at Odyssey Therapeutics, Ultragenyx, Ipsen, and Sanofi, Julie is known for driving growth, building high-performing teams, and transforming organizations to deliver meaningful impact for patients.